STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma.
Zhang L, Nesvick CL, Day CA, Choi J, Lu VM, Peterson T, Power EA, Anderson JB, Hamdan FH, Decker PA, Simons R, Welby JP, Siada R, Ge J, Kaptzan T, Johnsen SA, Hinchcliffe EH, Daniels DJ.
Zhang L, et al. Among authors: day ca.
Neuro Oncol. 2022 Oct 3;24(10):1700-1711. doi: 10.1093/neuonc/noac093.
Neuro Oncol. 2022.
PMID: 35397475
Free PMC article.